Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 198

1.

Automatic Spinal Cord Gray Matter Quantification: A Novel Approach.

Tsagkas C, Horvath A, Altermatt A, Pezold S, Weigel M, Haas T, Amann M, Kappos L, Sprenger T, Bieri O, Cattin P, Parmar K.

AJNR Am J Neuroradiol. 2019 Sep;40(9):1592-1600. doi: 10.3174/ajnr.A6157. Epub 2019 Aug 22.

PMID:
31439628
2.

Fat/water separation in k-space with real-valued estimates and its combination with POCS.

Berglund J, Rydén H, Avventi E, Norbeck O, Sprenger T, Skare S.

Magn Reson Med. 2019 Aug 16. doi: 10.1002/mrm.27949. [Epub ahead of print]

PMID:
31418932
3.

Short timescale modulation of cortical and cerebellar activity in the early phase of motor sequence learning: an fMRI study.

Magon S, Pfister A, Laura G, Lüthi M, Papadopoulou A, Kappos L, Sprenger T.

Brain Imaging Behav. 2019 Jul 27. doi: 10.1007/s11682-019-00167-8. [Epub ahead of print]

PMID:
31352651
4.

Association of brain volume loss and long-term disability outcomes in patients with multiple sclerosis treated with teriflunomide.

Sprenger T, Kappos L, Radue EW, Gaetano L, Mueller-Lenke N, Wuerfel J, Poole EM, Cavalier S.

Mult Scler. 2019 Jun 14:1352458519855722. doi: 10.1177/1352458519855722. [Epub ahead of print]

PMID:
31198103
5.

Hiatal hernias in patients with GERD-like symptoms: evaluation of dynamic real-time MRI vs endoscopy.

Seif Amir Hosseini A, Uhlig J, Streit U, Uhlig A, Sprenger T, Wedi E, Ellenrieder V, Ghadimi M, Uecker M, Voit D, Frahm J, Lotz J, Biggemann L.

Eur Radiol. 2019 Jun 11. doi: 10.1007/s00330-019-06284-8. [Epub ahead of print]

PMID:
31187219
6.

Multi-shot Echo Planar Imaging for accelerated Cartesian MR Fingerprinting: An alternative to conventional spiral MR Fingerprinting.

Benjamin AJV, Gómez PA, Golbabaee M, Mahbub ZB, Sprenger T, Menzel MI, Davies M, Marshall I.

Magn Reson Imaging. 2019 Sep;61:20-32. doi: 10.1016/j.mri.2019.04.014. Epub 2019 May 10.

PMID:
31082496
7.

Damage of the lateral geniculate nucleus in MS: Assessing the missing node of the visual pathway.

Papadopoulou A, Gaetano L, Pfister A, Altermatt A, Tsagkas C, Morency F, Brandt AU, Hardmeier M, Chakravarty MM, Descoteaux M, Kappos L, Sprenger T, Magon S.

Neurology. 2019 May 7;92(19):e2240-e2249. doi: 10.1212/WNL.0000000000007450. Epub 2019 Apr 10.

PMID:
30971483
8.

Diagnostic performance of a new multicontrast one-minute full brain exam (EPIMix) in neuroradiology: A prospective study.

Delgado AF, Kits A, Bystam J, Kaijser M, Skorpil M, Sprenger T, Skare S.

J Magn Reson Imaging. 2019 Apr 1. doi: 10.1002/jmri.26742. [Epub ahead of print]

PMID:
30932287
9.

Real-time MRI for the dynamic assessment of fundoplication failure in patients with gastroesophageal reflux disease.

Seif Amir Hosseini A, Uhlig J, Streit U, Voit D, Uhlig A, Ellenrieder V, Ghadimi M, Sprenger T, Beham A, Uecker M, Frahm J, Lotz J, Biggemann L.

Eur Radiol. 2019 Sep;29(9):4691-4698. doi: 10.1007/s00330-019-06025-x. Epub 2019 Feb 25.

PMID:
30805702
10.

Clinical associations of T2-weighted lesion load and lesion location in small vessel disease: Insights from a large prospective cohort study.

Altermatt A, Gaetano L, Magon S, Bauer L, Feurer R, Gnahn H, Hartmann J, Seifert CL, Poppert H, Wuerfel J, Radue EW, Kappos L, Sprenger T.

Neuroimage. 2019 Apr 1;189:727-733. doi: 10.1016/j.neuroimage.2019.01.052. Epub 2019 Jan 24.

PMID:
30685330
11.

Hepatic arterial infusion of irinotecan and EmboCept® S results in high tumor concentration of SN-38 in a rat model of colorectal liver metastases.

Kauffels A, Kitzmüller M, Gruber A, Nowack H, Bohnenberger H, Spitzner M, Kuthning A, Sprenger T, Czejka M, Ghadimi M, Sperling J.

Clin Exp Metastasis. 2019 Feb;36(1):57-66. doi: 10.1007/s10585-019-09954-5. Epub 2019 Jan 24.

PMID:
30680598
12.

Cortical abnormalities in episodic migraine: A multi-center 3T MRI study.

Magon S, May A, Stankewitz A, Goadsby PJ, Schankin C, Ashina M, Amin FM, Seifert CL, Mallar Chakravarty M, Müller J, Sprenger T.

Cephalalgia. 2019 Apr;39(5):665-673. doi: 10.1177/0333102418795163. Epub 2018 Dec 10.

PMID:
30525946
13.

Design and construction of an innovative brain phantom prototype for MRI.

Altermatt A, Santini F, Deligianni X, Magon S, Sprenger T, Kappos L, Cattin P, Wuerfel J, Gaetano L.

Magn Reson Med. 2019 Feb;81(2):1165-1171. doi: 10.1002/mrm.27464. Epub 2018 Sep 17.

PMID:
30221790
14.

A comparison of brain magnetic resonance imaging lesions in multiple sclerosis by race with reference to disability progression.

Nakamura Y, Gaetano L, Matsushita T, Anna A, Sprenger T, Radue EW, Wuerfel J, Bauer L, Amann M, Shinoda K, Isobe N, Yamasaki R, Saida T, Kappos L, Kira JI.

J Neuroinflammation. 2018 Sep 5;15(1):255. doi: 10.1186/s12974-018-1295-1.

15.

MRI-based prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis using SVM and lesion geometry.

Bendfeldt K, Taschler B, Gaetano L, Madoerin P, Kuster P, Mueller-Lenke N, Amann M, Vrenken H, Wottschel V, Barkhof F, Borgwardt S, Klöppel S, Wicklein EM, Kappos L, Edan G, Freedman MS, Montalbán X, Hartung HP, Pohl C, Sandbrink R, Sprenger T, Radue EW, Wuerfel J, Nichols TE.

Brain Imaging Behav. 2019 Oct;13(5):1361-1374. doi: 10.1007/s11682-018-9942-9.

PMID:
30155789
16.

Shortening the washout to 4 weeks when switching from natalizumab to fingolimod and risk of disease reactivation in multiple sclerosis.

Naegelin Y, Rasenack M, Andelova M, Von Felten S, Fischer-Barnicol B, Amann M, Mehling M, Kappos L, Sprenger T, Derfuss T.

Mult Scler Relat Disord. 2018 Oct;25:14-20. doi: 10.1016/j.msard.2018.07.005. Epub 2018 Jul 6.

17.

Spinal cord volume loss: A marker of disease progression in multiple sclerosis.

Tsagkas C, Magon S, Gaetano L, Pezold S, Naegelin Y, Amann M, Stippich C, Cattin P, Wuerfel J, Bieri O, Sprenger T, Kappos L, Parmar K.

Neurology. 2018 Jul 24;91(4):e349-e358. doi: 10.1212/WNL.0000000000005853. Epub 2018 Jun 27.

PMID:
29950437
18.

Long-term prognostic impact of surgical complications in the German Rectal Cancer Trial CAO/ARO/AIO-94.

Sprenger T, Beißbarth T, Sauer R, Tschmelitsch J, Fietkau R, Liersch T, Hohenberger W, Staib L, Gaedcke J, Raab HR, Rödel C, Ghadimi M.

Br J Surg. 2018 Oct;105(11):1510-1518. doi: 10.1002/bjs.10877. Epub 2018 May 30.

PMID:
29846017
19.

Clinical Correlations of Brain Lesion Location in Multiple Sclerosis: Voxel-Based Analysis of a Large Clinical Trial Dataset.

Altermatt A, Gaetano L, Magon S, Häring DA, Tomic D, Wuerfel J, Radue EW, Kappos L, Sprenger T.

Brain Topogr. 2018 Sep;31(5):886-894. doi: 10.1007/s10548-018-0652-9. Epub 2018 May 29.

PMID:
29845492
20.

Cortical Thickness Alterations in Chronic Pain Disorder: An Exploratory MRI Study.

Magon S, Sprenger T, Otti A, Papadopoulou A, Gündel H, Noll-Hussong M.

Psychosom Med. 2018 Sep;80(7):592-598. doi: 10.1097/PSY.0000000000000605.

PMID:
29787468
21.

Preferential spinal cord volume loss in primary progressive multiple sclerosis.

Tsagkas C, Magon S, Gaetano L, Pezold S, Naegelin Y, Amann M, Stippich C, Cattin P, Wuerfel J, Bieri O, Sprenger T, Kappos L, Parmar K.

Mult Scler. 2019 Jun;25(7):947-957. doi: 10.1177/1352458518775006. Epub 2018 May 21.

PMID:
29781383
22.

Current Prophylactic Medications for Migraine and Their Potential Mechanisms of Action.

Sprenger T, Viana M, Tassorelli C.

Neurotherapeutics. 2018 Apr;15(2):313-323. doi: 10.1007/s13311-018-0621-8. Review.

23.

Fingolimod effect on gray matter, thalamus, and white matter in patients with multiple sclerosis.

Gaetano L, Häring DA, Radue EW, Mueller-Lenke N, Thakur A, Tomic D, Kappos L, Sprenger T.

Neurology. 2018 Apr 10;90(15):e1324-e1332. doi: 10.1212/WNL.0000000000005292. Epub 2018 Mar 14.

PMID:
29540589
24.

The role of the cerebellum in multiple sclerosis-150 years after Charcot.

Parmar K, Stadelmann C, Rocca MA, Langdon D, D'Angelo E, D'Souza M, Burggraaff J, Wegner C, Sastre-Garriga J, Barrantes-Freer A, Dorn J, Uitdehaag BMJ, Montalban X, Wuerfel J, Enzinger C, Rovira A, Tintore M, Filippi M, Kappos L, Sprenger T; MAGNIMS study group.

Neurosci Biobehav Rev. 2018 Jun;89:85-98. doi: 10.1016/j.neubiorev.2018.02.012. Epub 2018 Feb 23. Review.

PMID:
29477616
25.

Superior Effects of High-Intensity Interval Training vs. Moderate Continuous Training on Arterial Stiffness in Episodic Migraine: A Randomized Controlled Trial.

Hanssen H, Minghetti A, Magon S, Rossmeissl A, Papadopoulou A, Klenk C, Schmidt-Trucksäss A, Faude O, Zahner L, Sprenger T, Donath L.

Front Physiol. 2017 Dec 19;8:1086. doi: 10.3389/fphys.2017.01086. eCollection 2017.

26.

Effects of different endurance exercise modalities on migraine days and cerebrovascular health in episodic migraineurs: A randomized controlled trial.

Hanssen H, Minghetti A, Magon S, Rossmeissl A, Rasenack M, Papadopoulou A, Klenk C, Faude O, Zahner L, Sprenger T, Donath L.

Scand J Med Sci Sports. 2018 Mar;28(3):1103-1112. doi: 10.1111/sms.13023. Epub 2018 Jan 8.

PMID:
29161767
27.

A 1-minute full brain MR exam using a multicontrast EPI sequence.

Skare S, Sprenger T, Norbeck O, Rydén H, Blomberg L, Avventi E, Engström M.

Magn Reson Med. 2018 Jun;79(6):3045-3054. doi: 10.1002/mrm.26974. Epub 2017 Oct 31.

PMID:
29090483
28.

Two-year results from a phase 2 extension study of oral amiselimod in relapsing multiple sclerosis.

Kappos L, Arnold DL, Bar-Or A, Camm AJ, Derfuss T, Sprenger T, Davies M, Piotrowska A, Ni P, Harada T.

Mult Scler. 2018 Oct;24(12):1605-1616. doi: 10.1177/1352458517728343. Epub 2017 Sep 15.

29.

Altered thalamic connectivity during spontaneous attacks of migraine without aura: A resting-state fMRI study.

Amin FM, Hougaard A, Magon S, Sprenger T, Wolfram F, Rostrup E, Ashina M.

Cephalalgia. 2018 Jun;38(7):1237-1244. doi: 10.1177/0333102417729113. Epub 2017 Aug 30.

PMID:
28853611
30.

Daclizumab for the treatment of multiple sclerosis.

Papadopoulou A, Derfuss T, Sprenger T.

Neurodegener Dis Manag. 2017 Oct;7(5):279-297. doi: 10.2217/nmt-2017-0023. Epub 2017 Aug 29. Review.

PMID:
28849702
31.

Teriflunomide slows BVL in relapsing MS: A reanalysis of the TEMSO MRI data set using SIENA.

Radue EW, Sprenger T, Gaetano L, Mueller-Lenke N, Cavalier S, Thangavelu K, Panzara MA, Donaldson JE, Woodward FM, Wuerfel J, Wolinsky JS, Kappos L.

Neurol Neuroimmunol Neuroinflamm. 2017 Aug 9;4(5):e390. doi: 10.1212/NXI.0000000000000390. eCollection 2017 Sep.

32.

The Prognostic Value of Tyrosine Kinase SRC Expression in Locally Advanced Rectal Cancer.

Rühlmann F, Nietert M, Sprenger T, Wolff HA, Homayounfar K, Middel P, Bohnenberger H, Beissbarth T, Ghadimi BM, Liersch T, Conradi LC.

J Cancer. 2017 Apr 10;8(7):1229-1237. doi: 10.7150/jca.16980. eCollection 2017.

33.

Tracking the Evolution of Cerebral Gadolinium-Enhancing Lesions to Persistent T1 Black Holes in Multiple Sclerosis: Validation of a Semiautomated Pipeline.

Andermatt S, Papadopoulou A, Radue EW, Sprenger T, Cattin P.

J Neuroimaging. 2017 Sep;27(5):469-475. doi: 10.1111/jon.12439. Epub 2017 Mar 30.

PMID:
28370651
34.

Model-based denoising in diffusion-weighted imaging using generalized spherical deconvolution.

Sperl JI, Sprenger T, Tan ET, Menzel MI, Hardy CJ, Marinelli L.

Magn Reson Med. 2017 Dec;78(6):2428-2438. doi: 10.1002/mrm.26626. Epub 2017 Feb 28.

PMID:
28244188
35.

Factors associated with significant MRI findings in medical walk-in patients with acute headache.

Budweg J, Sprenger T, De Vere-Tyndall A, Hagenkord A, Stippich C, Berger CT.

Swiss Med Wkly. 2016 Dec 8;146:w14349. doi: 10.4414/smw.2016.14349. eCollection 2016.

36.

Association of clinical headache features with stroke location: An MRI voxel-based symptom lesion mapping study.

Seifert CL, Schönbach EM, Zimmer C, Förschler A, Tölle TR, Feurer R, Gempt J, Papadopoulou A, Magon S, Sprenger T, Poppert H.

Cephalalgia. 2018 Feb;38(2):283-291. doi: 10.1177/0333102416686342. Epub 2016 Dec 22.

PMID:
28006971
37.

When cervical pain is actually migraine: An observational study in 207 patients.

Viana M, Sances G, Terrazzino S, Sprenger T, Nappi G, Tassorelli C.

Cephalalgia. 2018 Feb;38(2):383-388. doi: 10.1177/0333102416683917. Epub 2016 Dec 7.

PMID:
27927894
38.

Factors associated with significant MRI findings in medical walk-in patients with acute headache.

Budweg J, Sprenger T, De Vere-Tyndall A, Hagenkord A, Stippich C, Berger CT.

Swiss Med Wkly. 2016 Dec 5;146:w14349. doi: 10.4414/smw.2016.14349. eCollection 2016 Dec 5. No abstract available.

39.

Safety and efficacy of amiselimod in relapsing multiple sclerosis (MOMENTUM): a randomised, double-blind, placebo-controlled phase 2 trial.

Kappos L, Arnold DL, Bar-Or A, Camm J, Derfuss T, Kieseier BC, Sprenger T, Greenough K, Ni P, Harada T.

Lancet Neurol. 2016 Oct;15(11):1148-59. doi: 10.1016/S1474-4422(16)30192-2. Epub 2016 Aug 16.

PMID:
27543447
40.

Striatal functional connectivity changes following specific balance training in elderly people: MRI results of a randomized controlled pilot study.

Magon S, Donath L, Gaetano L, Thoeni A, Radue EW, Faude O, Sprenger T.

Gait Posture. 2016 Sep;49:334-339. doi: 10.1016/j.gaitpost.2016.07.016. Epub 2016 Jul 19.

PMID:
27479219
41.

Safety and efficacy of daclizumab in relapsing-remitting multiple sclerosis: 3-year results from the SELECTED open-label extension study.

Gold R, Radue EW, Giovannoni G, Selmaj K, Havrdova E, Stefoski D, Sprenger T, Montalban X, Cohan S, Umans K, Greenberg SJ, Ozen G, Elkins J.

BMC Neurol. 2016 Jul 26;16:117. doi: 10.1186/s12883-016-0635-y.

42.

Defining brain volume cutoffs to identify clinically relevant atrophy in RRMS.

Sormani MP, Kappos L, Radue EW, Cohen J, Barkhof F, Sprenger T, Piani Meier D, Häring D, Tomic D, De Stefano N.

Mult Scler. 2017 Apr;23(5):656-664. doi: 10.1177/1352458516659550. Epub 2016 Jul 18.

PMID:
27411701
43.

Assessing response to interferon-β in a multicenter dataset of patients with MS.

Sormani MP, Gasperini C, Romeo M, Rio J, Calabrese M, Cocco E, Enzingher C, Fazekas F, Filippi M, Gallo A, Kappos L, Marrosu MG, Martinelli V, Prosperini L, Rocca MA, Rovira A, Sprenger T, Stromillo ML, Tedeschi G, Tintorè M, Tortorella C, Trojano M, Montalban X, Pozzilli C, Comi G, De Stefano N; MAGNIMS study group.

Neurology. 2016 Jul 12;87(2):134-40. doi: 10.1212/WNL.0000000000002830. Epub 2016 Jun 15.

PMID:
27306626
44.

Effect of fingolimod on diffuse brain tissue damage in relapsing-remitting multiple sclerosis patients.

De Stefano N, Tomic D, Radue EW, Sprenger T, Meier DP, Häring D, Sormani MP.

Mult Scler Relat Disord. 2016 May;7:98-101. doi: 10.1016/j.msard.2016.03.017. Epub 2016 Mar 31.

PMID:
27237768
45.

Ictal lack of binding to brain parenchyma suggests integrity of the blood-brain barrier for 11C-dihydroergotamine during glyceryl trinitrate-induced migraine.

Schankin CJ, Maniyar FH, Seo Y, Kori S, Eller M, Chou DE, Blecha J, Murphy ST, Hawkins RA, Sprenger T, VanBrocklin HF, Goadsby PJ.

Brain. 2016 Jul;139(Pt 7):1994-2001. doi: 10.1093/brain/aww096. Epub 2016 May 27.

46.

Reliable volumetry of the cervical spinal cord in MS patient follow-up data with cord image analyzer (Cordial).

Amann M, Pezold S, Naegelin Y, Fundana K, Andělová M, Weier K, Stippich C, Kappos L, Radue EW, Cattin P, Sprenger T.

J Neurol. 2016 Jul;263(7):1364-74. doi: 10.1007/s00415-016-8133-0. Epub 2016 May 9.

PMID:
27159989
47.

[Lymph node metastases in ypT1/2 rectal cancer after neoadjuvant chemoradiotherapy : The Achilles heel of organ-preserving operative procedures?].

Sprenger T, Rothe H, Beissbarth T, Conradi LC, Kauffels A, Homayounfar K, Behnes CL, Rödel C, Liersch T, Ghadimi M.

Chirurg. 2016 Jul;87(7):593-601. doi: 10.1007/s00104-016-0170-9. German.

PMID:
27106241
48.

Stage-Dependent Frequency of Lymph Node Metastases in Patients With Rectal Carcinoma After Preoperative Chemoradiation: Results from the CAO/ARO/AIO-94 Trial and From a Comparative Prospective Evaluation With Extensive Pathological Workup.

Sprenger T, Rothe H, Conradi LC, Beissbarth T, Kauffels A, Kitz J, Homayounfar K, Wolff H, Ströbel P, Ghadimi M, Wittekind C, Sauer R, Rödel C, Liersch T.

Dis Colon Rectum. 2016 May;59(5):377-85. doi: 10.1097/DCR.0000000000000570.

PMID:
27050599
49.

Power estimation for non-standardized multisite studies.

Keshavan A, Paul F, Beyer MK, Zhu AH, Papinutto N, Shinohara RT, Stern W, Amann M, Bakshi R, Bischof A, Carriero A, Comabella M, Crane JC, D'Alfonso S, Demaerel P, Dubois B, Filippi M, Fleischer V, Fontaine B, Gaetano L, Goris A, Graetz C, Gröger A, Groppa S, Hafler DA, Harbo HF, Hemmer B, Jordan K, Kappos L, Kirkish G, Llufriu S, Magon S, Martinelli-Boneschi F, McCauley JL, Montalban X, Mühlau M, Pelletier D, Pattany PM, Pericak-Vance M, Cournu-Rebeix I, Rocca MA, Rovira A, Schlaeger R, Saiz A, Sprenger T, Stecco A, Uitdehaag BMJ, Villoslada P, Wattjes MP, Weiner H, Wuerfel J, Zimmer C, Zipp F; International Multiple Sclerosis Genetics Consortium. Electronic address: AIVINSON@PARTNERS.ORG, Hauser SL, Oksenberg JR, Henry RG.

Neuroimage. 2016 Jul 1;134:281-294. doi: 10.1016/j.neuroimage.2016.03.051. Epub 2016 Apr 1.

50.

The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options.

Disanto G, Benkert P, Lorscheider J, Mueller S, Vehoff J, Zecca C, Ramseier S, Achtnichts L, Findling O, Nedeltchev K, Radue EW, Sprenger T, Stippich C, Derfuss T, Louvion JF, Kamm CP, Mattle HP, Lotter C, Du Pasquier R, Schluep M, Pot C, Lalive PH, Yaldizli Ö, Gobbi C, Kappos L, Kuhle J; SMSC Scientific Board.

PLoS One. 2016 Mar 31;11(3):e0152347. doi: 10.1371/journal.pone.0152347. eCollection 2016.

Supplemental Content

Loading ...
Support Center